KL
About
Dr. Kevin Li is a Partner at DT Capital responsible for healthcare and life science investments. Prior to DT, Kevin was the Chief Scientific Officer of China Nuokang Biopharma (Nasdaq:NKBP), a leading biopharmaceutical company in China, and a Partner at HBM BioMed China, a Shanghai‐based venture capital fund affiliated with the HBM Bioventures, and focused on biomedical investment opportunities. Kevin has over 10 years of professional experience in biomedical sciences, healthcare investment and entrepreneurship. PhD Indiana University; Postdoc Stanford University.
Position in the VCSift Database
- • 7 investors at DT Capital Partners are tracked.
- • 2,531 investors hold the Partner role in VCSift. Kevin Li is one of them.
- • 1,074 investors are based in Shanghai, Shanghai, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Shanghai, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Kevin
Search Investors